{
  "pmcid": "11701169",
  "sha256": "1a270f7c64c33e3253972c7d3d1bb73e28a2c7b2b8aca8549241cc6d1f613d0c",
  "timestamp_utc": "2025-11-09T23:19:01.642855+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.906150000000004,
    "reading_ease": 16.02282500000001,
    "word_count": 250
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Ultrasound-Guided Stellate Ganglion Blockade in Thoracoscopic Pulmonary Lobectomy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "88 patients were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients aged 18-75 undergoing elective thoracoscopic pulmonary lobectomy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either SGB (n=40) or standard care (n=39)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the potential of ultrasound-guided stellate ganglion blockade (SGB) to mitigate these complications."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in oxygenation index (OI) and pulmonary shunt fraction (Qs/Qt) during SLV, measured at multiple time points."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included patients, clinicians, and outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "88 patients were randomised"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "SGB significantly improved OI and reduced Qs/Qt compared to controls."
      },
      "Harms": {
        "score": 1,
        "evidence": "No severe adverse events were reported, with mild complications occurring in 3% of the SGB group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Chinese Clinical Trial Registry (#ChiCTR2200063210)."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}